Hudson Bay Capital Management LP - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 177 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.06 and the average weighting 0.2%.

Quarter-by-quarter ownership
Hudson Bay Capital Management LP ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$2,218,000
-30.1%
110,000
+29.4%
0.03%
-21.1%
Q2 2021$3,171,000
-24.8%
84,976
-48.5%
0.04%
-26.9%
Q1 2021$4,219,000
-43.7%
165,000
-51.5%
0.05%
+30.0%
Q4 2020$7,490,000
+26.2%
340,000
+3.0%
0.04%
-54.5%
Q3 2020$5,937,000
+11.3%
330,000
+57.1%
0.09%
-5.4%
Q2 2020$5,334,000210,0000.09%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,355,392$29,859,0006.21%
Bain Capital Life Sciences Investors, LLC 3,080,237$67,858,0004.26%
DAFNA Capital Management LLC 587,756$12,948,0003.85%
SILVERARC CAPITAL MANAGEMENT, LLC 227,388$5,009,0002.91%
RTW INVESTMENTS, LP 7,253,857$159,802,0002.68%
Parkman Healthcare Partners LLC 331,513$7,303,0001.87%
Evolutionary Tree Capital Management, LLC 60,864$1,341,0001.02%
Eagle Health Investments LP 69,000$1,520,0000.97%
Woodline Partners LP 1,358,796$29,934,0000.79%
Affinity Asset Advisors, LLC 40,000$881,0000.47%
View complete list of DICERNA PHARMACEUTICALS INC shareholders